Corrigendum to “(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors” [Bioorg. Med. Chem. Lett. 15 (2005) 3402–3406]